Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists

The present invention relates to compounds of formula 1 that are useful as an active ingredient of a medicament for preventive and/or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokines. The invention relates furthermore to a process for the preparation of said compou...

Full description

Saved in:
Bibliographic Details
Main Authors Bartane Bodor, Veronika, Smrcina, Martin, S.Thorpe, David, Szeleczky, Gabor, Patek, Marcel, Vasas, Attila, Ferenczy, Gyorgy, Budzer-Lantos, Peter, Bata, Imre, Batori, Sandor, Tomoskozi, Zsuzsanna, Weichsel, Aleksandra
Format Patent
LanguageEnglish
Published 20.07.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to compounds of formula 1 that are useful as an active ingredient of a medicament for preventive and/or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokines. The invention relates furthermore to a process for the preparation of said compounds, to pharmaceutical compositions containing said compounds and to the novel intermediates used in the preparation of said compounds.
Bibliography:Application Number: AU20120349866